Skip to Content
Morningstar

Fidelity Advisor Biotechnology A FBTAX

Morningstar Medalist Rating
Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 32.81  /  +1.05 %
  • Total Assets 1.7 Bil
  • Adj. Expense Ratio
    1.010%
  • Expense Ratio 1.010%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment —
  • Status Open
  • TTM Yield 1.05%
  • Turnover 78%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0

Morningstar’s Analysis FBTAX

Will FBTAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FBTAX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FBTAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FBTAX’s parent organization’s priorities and whether they’re in line with investors’ interests.

An upgrade in its Process Pillar rating is the primary driver of Fidelity Advisor Biotechnology A's upgrade to a Morningstar Medalist Rating of Silver from Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBTAX

More FBTAX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 62.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

19.17 314.3 Mil
Healthcare

Amgen Inc

9.58 157.1 Mil
Healthcare

Regeneron Pharmaceuticals Inc

8.52 139.8 Mil
Healthcare

Vertex Pharmaceuticals Inc

7.12 116.8 Mil
Healthcare

Ascendis Pharma A/S ADR

3.91 64.1 Mil
Healthcare

Alnylam Pharmaceuticals Inc

3.43 56.3 Mil
Healthcare

argenx SE ADR

3.41 55.9 Mil
Healthcare

Viking Therapeutics Inc

2.72 44.6 Mil
Healthcare

Vaxcyte Inc Ordinary Shares

2.57 42.1 Mil
Healthcare

Cytokinetics Inc

1.68 27.5 Mil
Healthcare